- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Fuji expands U.S. x-ray imaging operations
Fuji expands U.S. x-ray imaging operationsIn a strong indication that its x-ray film business is healthy and growing, Fuji Photo Film has embarked on a $300-million expansion of its manufacturing and distribution operations in Greenville, SC.
Fuji expands U.S. x-ray imaging operations
In a strong indication that its x-ray film business is healthy and growing, Fuji Photo Film has embarked on a $300-million expansion of its manufacturing and distribution operations in Greenville, SC. The project includes two new manufacturing facilitiesone for color photographic film and photographic paper, the other for x-ray film finishingand a major extension to the companys existing distribution center. Fuji plans to have the two new factories up and running early next year.
The move is expected to have a positive impact on Fuji Medical Systems conventional and digital x-ray imaging businesses and its enterprise-wide image and information management systems business, according to Clay Larsen, managing director of marketing for Fuji Medical Systems USA, which opened a U.S. manufacturing facility for digital medical imaging equipment and software last August. In particular, it should complement the companys efforts to help customers transition to a filmless environment.
Many customers dont want to treat computed radiography, digital x-ray, and PACS separately, Larsen said. They want to bundle film and CR or CR and PACS or put them all together into a plan to transition from film and lasers to CR and PACS. What a lot of people dont realize is that, as customers go to digital x-ray, there are going to have to be interim printing solutions before they go completely filmless.
© 2000 Miller Freeman, Inc., a United News & Media company.
- Search again
- Homepage
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
April 19th 2024One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
